MUC19 and Parkinson disease: Compared with non-carriers, the G2385R carriers simultaneously carrying the heterozygous (Het) and homozygous (Hom) MUC19 deletion had a significantly lower chance of developing PD than those carrying the wild-type (WT) MUC19 deletion (P < 0.05) (Fig. 5a).